Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (1-10 of 364) with videos related to

Pageof 37
Sort By:
Oncoimmunology|October 3, 2022
Is ferroptosis immunogenic? The devil is in the details!Oliver Kepp, Guido Kroemer
International Review of Cell and Molecular Biology|March 7, 2020
Preface: Endoplasmic reticulum in health and diseaseOliver Kepp, Lorenzo Galluzzi
Methods in Cell Biology|March 30, 2026
2D and 3D cellular screening models and AI guided analysisOliver Kepp, Guido Kroemer
Methods in Cell Biology|July 6, 2021
Vesicular trafficking in cellular responses to stressOliver Kepp, Lorenzo Galluzzi
Oncoimmunology|November 19, 2025
FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancerOliver Kepp, Guido Kroemer
Methods in Cell Biology|July 27, 2021
Vesicular trafficking in cellular responses to stressOliver Kepp, Lorenzo Galluzzi
Oncoimmunology|March 3, 2020
A novel platinum-based chemotherapeutic inducing immunogenic cell deathOliver Kepp, Guido Kroemer
Oncoimmunology|July 15, 2025
Immunogenic cell death and bystander killing: expanding the therapeutic potential of modern antibody-drug conjugatesOliver Kepp, Guido Kroemer
Cells|December 22, 2023
Immunogenic Cell Stress and Death Sensitize Tumors to ImmunotherapyOliver Kepp, Guido Kroemer
Nature Cancer|February 5, 2022
Pseudovirus for immunotherapyOliver Kepp, Guido Kroemer
Pageof 37

Showing results (1-10 of 364) with videos related to

Sort By:
Pageof 37
Oncoimmunology|October 3, 2022
Is ferroptosis immunogenic? The devil is in the details!Oliver Kepp, Guido Kroemer
International Review of Cell and Molecular Biology|March 7, 2020
Preface: Endoplasmic reticulum in health and diseaseOliver Kepp, Lorenzo Galluzzi
Methods in Cell Biology|March 30, 2026
2D and 3D cellular screening models and AI guided analysisOliver Kepp, Guido Kroemer
Methods in Cell Biology|July 6, 2021
Vesicular trafficking in cellular responses to stressOliver Kepp, Lorenzo Galluzzi
Oncoimmunology|November 19, 2025
FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancerOliver Kepp, Guido Kroemer
Methods in Cell Biology|July 27, 2021
Vesicular trafficking in cellular responses to stressOliver Kepp, Lorenzo Galluzzi
Oncoimmunology|March 3, 2020
A novel platinum-based chemotherapeutic inducing immunogenic cell deathOliver Kepp, Guido Kroemer
Oncoimmunology|July 15, 2025
Immunogenic cell death and bystander killing: expanding the therapeutic potential of modern antibody-drug conjugatesOliver Kepp, Guido Kroemer
Cells|December 22, 2023
Immunogenic Cell Stress and Death Sensitize Tumors to ImmunotherapyOliver Kepp, Guido Kroemer
Nature Cancer|February 5, 2022
Pseudovirus for immunotherapyOliver Kepp, Guido Kroemer
Pageof 37